GFM
IMCR icon

GF Fund Management’s Immunocore IMCR Stock Holding History

GF Fund Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5K Sell
929
-51
-5% -$1.51K ﹤0.01% 449
2026
Q1 		$29.5K Buy
980
+123
+14% +$3.98K ﹤0.01% 457
2025
Q4 		$29.7K Sell
857
-5
-0.6% -$177 ﹤0.01% 457
2025
Q3 		$31.3K Sell
862
-152
-15% -$5.16K ﹤0.01% 438
2025
Q2 		$31.8K Hold
1,014
– – ﹤0.01% 452
2025
Q1 		$30.1K Buy
1,014
+183
+22% +$5.49K ﹤0.01% 458
2024
Q4 		$24.5K Buy
+831
New +$26.3K ﹤0.01% 454

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

GF Fund Management's IMCR Position: Q2 2026 in Review

GF Fund Management reduced its Immunocore (IMCR) stake by 5.2% in Q2 2026, selling an estimated $1.51K and leaving 929 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

GF Fund Management first reported a position in IMCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.8K in Q2 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • GF Fund Management held 929 shares of Immunocore worth $29.5K as of Q2 2026.
  • GF Fund Management sold 51 Immunocore shares in Q2 2026, an estimated $1.51K.
  • Immunocore made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #449 holding.
  • GF Fund Management first reported a position in Immunocore in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Immunocore position peaked at $31.8K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.